Open access · CC-BY
via OpenAlex
Insulin and glycolysis dependency of cardioprotection by nicotinamide riboside
Y. Xiao, Q. Wang, Hong Zhang, Rianne Nederlof, Diane Bakker, Begawan A. Siadari, M. W. Wesselink, Benedikt Preckel, Nina Claudia Weber, Markus Werner Hollmann, Bauke V. Schomakers, Michel van Weeghel, Coert Jozef Zuurbier
Basic Research in Cardiology · 2024 · ▲ 7 citations
Abstract
Abstract Decreased nicotinamide adenine dinucleotide (NAD + ) levels contribute to various pathologies such as ageing, diabetes, heart failure and ischemia–reperfusion injury (IRI). Nicotinamide riboside (NR) has emerged as a promising therapeutic NAD + precursor due to efficient NAD + elevation and was recently shown to be the only agent able to reduce cardiac IRI in models employing clinically relevant anesthesia. However, through which metabolic pathway(s) NR mediates IRI protection remains unknown. Furthermore, the influence of insulin, a known modulator of cardioprotective efficacy, on the protective effects of NR has not been investigated. Here, we used the isolated mouse heart allowing cardiac metabolic control to investigate: (1) whether NR can protect the isolated heart against IRI, (2) the metabolic pathways underlying NR-mediated protection, and (3) whether insulin abrogates NR protection. NR protection against cardiac IRI and effects on metabolic pathways employing metabolomics for determination of changes in metabolic intermediates, and 13 C-glucose fluxomics for determination of metabolic pathway activities (glycolysis, pentose phosphate pathway (PPP) and mitochondrial/tricarboxylic acid cycle (TCA cycle) activities), were examined in isolated C57BL/6N mouse hearts perfused with either (a) glucose + fatty acids (FA) (“mild glycolysis group”), (b) lactate + pyruvate + FA (“no glycolysis group”), or (c) glucose + FA + insulin (“high glycolysis group”). NR increased cardiac NAD + in all three metabolic groups. In glucose + FA perfused hearts, NR reduced IR injury, increased glycolytic intermediate phosphoenolpyruvate (PEP), TCA intermediate succinate and PPP intermediates ribose-5P (R5P) / sedoheptulose-7P (S7P), and was associated with activated glycolysis, without changes in TCA cycle or PPP activities. In the “no glycolysis” hearts, NR protection was lost, whereas NR still increased S7P. In the insulin hearts, glycolysis was largely accelerated, and NR protection abrogated. NR still increased PPP intermediates, with now high 13 C-labeling of S7P, but NR was unable to increase metabolic pathway activities, including glycolysis. Protection by NR against IRI is only present in hearts with low glycolysis, and is associated with activation of glycolysis. When activation of glycolysis was prevented, through either examining “no glycolysis” hearts or “high glycolysis” hearts, NR protection was abolished. The data suggest that NR’s acute cardioprotective effects are mediated through glycolysis activation and are lost in the presence of insulin because of already elevated glycolysis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s00395-024-01042-4
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Xiao, Y., Wang, Q., Zhang, H., Nederlof, R., Bakker, D., Siadari, B.A., Wesselink, M.W., Preckel, B., Weber, N.C., Hollmann, M.W., Schomakers, B.V., Weeghel, M.V., & Zuurbier, C.J. (2024). Insulin and glycolysis dependency of cardioprotection by nicotinamide riboside. <em>Basic Research in Cardiology</em>. https://doi.org/10.1007/s00395-024-01042-4
Vancouver
Xiao Y, Wang Q, Zhang H, Nederlof R, Bakker D, Siadari BA, et al. Insulin and glycolysis dependency of cardioprotection by nicotinamide riboside. Basic Research in Cardiology. 2024. doi:10.1007/s00395-024-01042-4.
BibTeX
@article{y2024Insuli,
title = {Insulin and glycolysis dependency of cardioprotection by nicotinamide riboside},
author = {Y. Xiao and Q. Wang and Hong Zhang and Rianne Nederlof and Diane Bakker and Begawan A. Siadari and M. W. Wesselink and Benedikt Preckel and Nina Claudia Weber and Markus Werner Hollmann and Bauke V. Schomakers and Michel van Weeghel and Coert Jozef Zuurbier},
journal = {Basic Research in Cardiology},
year = {2024},
doi = {10.1007/s00395-024-01042-4},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2019
Open access · CC-BY
Epicatechin modulates stress-resistance in C. elegans via insulin/IGF-1 signaling pathway
Scientific Reports 2016
Open access · CC-BY
Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
Oxidative Medicine and Cellular Longevity 2017
Open access · CC-BY
Insights for Oxidative Stress and mTOR Signaling in Myocardial Ischemia/Reperfusion Injury under Diabetes
The Journal of Physiology 2012
Preprint · OA
Potentiating exercise training with resveratrol
Journal of Endocrinology 2021
Open access · CC-BY
Nicotinamide riboside has minimal impact on energy metabolism in mouse models of mild obesity
International Journal of Molecular Sciences 2020
Open access · CC-BY